Bio Protocol vs IOST — how do they compare? Bio Protocol trades at Rp516.58 (market cap Rp1,15T, Rp264,79M 24h volume), while IOST trades at Rp12.39 (market cap Rp422M, Rp81,36M 24h volume). The key difference: Bio Protocol is far larger — about 2725.1× IOST's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 34,2B / 90B IOST (38%) for IOST. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and IOST for 78 Days on average.
| BIO | IOST | |
|---|---|---|
Market Cap | Rp1,15T | Rp422M |
Volume (24h) | Rp264,79M | Rp81,36M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 34,2B / 90B IOST (38%) |
Typical Hold Time | 16 Days | 78 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
IOST is trading at Rp12.34 with a market cap of Rp420.17M, showing a bearish technical signal overall. The asset is near key support at Rp12 and resistance at Rp13, with oversold RSI_6 suggesting potential for a short-term bounce. Only 38% of the max supply is in circulation, and the average hold time is 78 days, indicating some holder commitment. No major protocol updates or ecosystem news were identified recently.
The outlook remains cautious due to weak technicals and limited fundamental catalysts. Key opportunities include oversold conditions and low circulation rate, while risks involve bearish momentum, low liquidity, and general crypto market volatility. Investors should monitor for any network developments or shifts in market sentiment.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →IOST describes itself as an “ultra-fast,” fully fledged and decentralized blockchain network and ecosystem with its own nodes, wallets and based on the “next-generation” consensus protocol dubbed “proof-of-believability.”
Read more on IOST →